Geode Capital Management LLC Acquires 192,465 Shares of Omega Healthcare Investors, Inc. (NYSE:OHI)

Geode Capital Management LLC raised its holdings in Omega Healthcare Investors, Inc. (NYSE:OHI) by 3.1% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 6,426,129 shares of the real estate investment trust’s stock after purchasing an additional 192,465 shares during the quarter. Geode Capital Management LLC’s holdings in Omega Healthcare Investors were worth $261,589,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently made changes to their positions in the company. State Street Corp grew its position in Omega Healthcare Investors by 0.9% during the third quarter. State Street Corp now owns 12,339,753 shares of the real estate investment trust’s stock valued at $502,228,000 after buying an additional 114,085 shares during the period. Assetmark Inc. boosted its stake in Omega Healthcare Investors by 1.7% in the third quarter. Assetmark Inc. now owns 1,191,460 shares of the real estate investment trust’s stock valued at $48,492,000 after acquiring an additional 19,542 shares during the last quarter. BNP Paribas Financial Markets grew its position in shares of Omega Healthcare Investors by 120.8% during the 3rd quarter. BNP Paribas Financial Markets now owns 226,338 shares of the real estate investment trust’s stock valued at $9,212,000 after acquiring an additional 123,836 shares during the period. Daiwa Securities Group Inc. increased its stake in shares of Omega Healthcare Investors by 317.7% during the 3rd quarter. Daiwa Securities Group Inc. now owns 3,949,368 shares of the real estate investment trust’s stock worth $160,739,000 after purchasing an additional 3,003,845 shares during the last quarter. Finally, Caxton Associates LP bought a new stake in shares of Omega Healthcare Investors in the 2nd quarter worth approximately $1,652,000. 65.25% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other Omega Healthcare Investors news, COO Daniel J. Booth sold 56,725 shares of the business’s stock in a transaction that occurred on Friday, September 27th. The stock was sold at an average price of $40.25, for a total value of $2,283,181.25. Following the completion of the sale, the chief operating officer now owns 100,000 shares in the company, valued at approximately $4,025,000. The trade was a 36.19 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CFO Robert O. Stephenson sold 22,542 shares of the stock in a transaction that occurred on Friday, September 27th. The shares were sold at an average price of $40.19, for a total value of $905,962.98. Following the sale, the chief financial officer now directly owns 183,076 shares of the company’s stock, valued at approximately $7,357,824.44. This trade represents a 10.96 % decrease in their position. The disclosure for this sale can be found here. 1.37% of the stock is owned by corporate insiders.

Omega Healthcare Investors Stock Performance

Shares of NYSE OHI opened at $39.21 on Friday. The stock’s 50-day moving average is $40.38 and its 200 day moving average is $37.92. The stock has a market cap of $10.58 billion, a price-to-earnings ratio of 28.83, a P/E/G ratio of 1.21 and a beta of 0.98. Omega Healthcare Investors, Inc. has a 1-year low of $27.53 and a 1-year high of $44.42. The company has a current ratio of 6.48, a quick ratio of 6.48 and a debt-to-equity ratio of 1.10.

Omega Healthcare Investors Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Monday, November 4th were issued a $0.67 dividend. The ex-dividend date of this dividend was Monday, November 4th. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.83%. Omega Healthcare Investors’s payout ratio is 197.06%.

Analyst Ratings Changes

OHI has been the subject of several research reports. Royal Bank of Canada increased their price objective on Omega Healthcare Investors from $39.00 to $43.00 and gave the company a “sector perform” rating in a report on Monday, November 11th. Scotiabank increased their price target on Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “sector perform” rating in a research note on Monday, August 26th. Berenberg Bank started coverage on Omega Healthcare Investors in a research note on Friday, October 18th. They issued a “buy” rating and a $45.00 price objective on the stock. Mizuho increased their target price on shares of Omega Healthcare Investors from $35.00 to $37.00 and gave the stock a “neutral” rating in a research report on Thursday, December 5th. Finally, Wells Fargo & Company reiterated an “overweight” rating and issued a $43.00 target price (up previously from $40.00) on shares of Omega Healthcare Investors in a research note on Tuesday, October 1st. Six analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to MarketBeat, Omega Healthcare Investors currently has an average rating of “Moderate Buy” and a consensus price target of $40.18.

Omega Healthcare Investors Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.